JP Morgan Downgrades AMAG Pharmaceuticals To Neutral, PT To $20

Loading...
Loading...
JP Morgan has downgraded AMAG Pharmaceuticals
AMAG
from Overweight to Neutral and has lowered the price target from $28 to $20.
Market News and Data brought to you by Benzinga APIs
Posted In: DowngradesPrice TargetAnalyst RatingsAMAG PharmaceuticalsHealth CareJP MorganLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...